We can't find the internet
Attempting to reconnect
Something went wrong!
Hang in there while we get back on track
The NLRP3 Inflammasome as a Central Driver of Mastitis Pathogenesis: A Review
Summary
This review pulls together recent research on udder infections (mastitis) in dairy cows, finding that many different triggers—including bacteria, heat stress, and even nanoplastics—seem to activate the same internal "alarm system" in cells that drives inflammation and damage. This matters because it points scientists toward treatments like selenium, probiotics, and plant compounds that could fight mastitis without antibiotics, though most evidence so far comes from lab and mouse studies rather than actual dairy cattle. The nanoplastics angle is also a reminder that these tiny plastic particles—found throughout our environment—may trigger infl
Mastitis remains the most economically damaging disease of dairy production, and recent molecular work has converged on the NLRP3 inflammasome as a key integrative node of its pathogenesis. This narrative review integrates evidence published largely between 2015 and 2026 to show how diverse triggers—Staphylococcus aureus and Escherichia coli, lipopolysaccharide (LPS) and lipoteichoic acid (LTA), non-esterified fatty acids (NEFA), heat stress, environmental xenobiotics including nanoplastics, and microbiota-derived signals—may funnel into a common NLRP3–ASC–caspase-1–GSDMD axis that drives pyroptosis, blood–milk barrier disruption, and clinical disease. The review examines the potential obligatory role of reactive oxygen species (ROS), mitochondrial dysfunction, and selenoprotein-mediated redox control in licensing inflammasome assembly. It further evaluates the emerging gut–mammary and rumen–mammary axes that operate upstream of local epithelial activation. We survey a structurally diverse therapeutic landscape encompassing dietary selenium, probiotics, microbial metabolites, plant-derived nanovesicles, polyphenols, ginsenosides, and small-molecule NLRP3 antagonists, identifying recurring mechanistic motifs that suggest combinatorial regimens may yield additive benefit. Importantly, much of the evidence derives from in vitro and murine models, and we highlight the translational gaps that must be bridged before clinical application in dairy cattle. Finally, we map outstanding research gaps and propose priorities for translational work aimed at sustainable, antibiotic-sparing management of bovine mastitis.